Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

HLS Therapeutics Inc T.HLS

Alternate Symbol(s):  HLTRF

HLS Therapeutics Inc. is a pharmaceutical company focused on the acquisition and commercialization of late-stage development, commercial stage promoted and established branded pharmaceutical products in the North American markets. It is engaged in addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease. It is also focused on products targeting the central nervous system and cardiovascular therapeutic areas. Its products include Clozaril, CSAN Pronto, MyCare Psychiatry and Vascepa. Its Clozaril is an atypical antipsychotic indicated for the management of symptoms of treatment-resistant schizophrenia for the Canadian and United States markets. CSAN Pronto is a capillary point-of-care medical device designed to enhance and simplify the mandatory safety blood monitoring process for patients that are prescribed Clozaril. The Vascepa (icosapent ethyl capsules) is a single-molecule prescription product in use to reduce the risk of cardiovascular events.


TSX:HLS - Post by User

Bullboard Posts
Post by Pat123on Apr 25, 2018 12:36am
122 Views
Post# 27935878

Still happy with Chris Nutt

Still happy with Chris NuttWake up. The guy has collect $1M from the transaction + he has curiously elected to increase the compensation to $1.4M (for him and another employee but mostly for him) 3 weeks before the reverse takeover deal was announced. Good timning ;)  The same guy that was paid big bucks for 3 years to manage an empty shell. Frankly, in that situation, how can he justify the substantial raise. Shame on him. 

In addition, was he supposed to work on the GM settlement? How can you work for 3 years on the lawsuit and you were not awared about the HST?  He spent million on lawyers for advice.

He has not demonstrated anything to create value for shareholders.

It's been more than 6-7 weeks after the settlement and we haven't heard anything on the amount that we should receive. What kind of company is this? Smells bad!

Finally, our December value of $2.40 + GM settlement is now worth $1.88 (of which 0.30 will only be accessible in 1-2 years) + GM settlement. Excluding GM, we have lost more than 20% our value since the reverse takeover.  
Bullboard Posts